Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel chiral H3-receptor agonists.

R Lipp1, J M Arrang, J Buschmann

  • 1Institute of Pharmacy, Freie Universität Berlin, FRG.

Agents and Actions. Supplements
|January 1, 1991
PubMed
Summary

Researchers synthesized novel histamine derivatives, finding they are full agonists at H3-receptors. Alpha R, beta S-dimethylhistamine emerged as a highly potent and selective H3-receptor agonist, offering new therapeutic potential.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

RIFM fragrance ingredient safety assessment, citral, CAS Registry Number 5392-40-5.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020
Same author

RIFM fragrance ingredient safety assessment, methyl 3-methylthiopropionate, CAS Registry Number 13532-18-8.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020
Same author

RIFM fragrance ingredient safety assessment, dipropyl disulfide, CAS Registry Number 629-19-6.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020
Same author

Corrigendum to "RIFM fragrance ingredient safety assessment, coumarin, CAS registry number 91-64-5" [Food Chem. Toxicol. 130 (Suppl. 1) (2019) 110522].

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020
Same author

Corrigendum to "RIFM fragrance ingredient safety assessment, cinnamaldehyde, CAS Registry Number 104-55-2" [Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110710].

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020
Same author

Corrigendum to RIFM fragrance ingredient safety assessment, cinnamaldehyde, CAS Registry Number 104-55-2 [Food Chem. Toxicol. 134 (Suppl. 1) (2019) 110710].

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2020

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Neuroscience

Background:

  • Histamine receptors play crucial roles in various physiological processes.
  • Developing selective receptor agonists is key for targeted therapeutic interventions.
  • Histamine derivatives offer a scaffold for modulating receptor activity.

Purpose of the Study:

  • To synthesize and evaluate novel alkyl-substituted histamine derivatives.
  • To determine the agonistic potency of these compounds across three histamine receptor subtypes.
  • To identify highly potent and selective agonists for specific histamine receptors.

Main Methods:

  • Synthesis of a series of alkyl-substituted histamine derivatives.
  • In vitro assays to measure agonistic activity at histamine receptors.

Related Experiment Videos

  • Comparative analysis of compound potency relative to histamine.

    • Main Results:

    • All synthesized compounds demonstrated full agonistic activity at H3-receptors.
    • Significant variations in relative potency against histamine were observed.
    • Alpha R, beta S-dimethylhistamine exhibited exceptional potency and selectivity for H3-receptors.

    Conclusions:

    • Alkyl substitution can fine-tune the potency and selectivity of histamine derivatives.
    • Alpha R, beta S-dimethylhistamine represents a promising lead compound for H3-receptor targeted therapies.
    • Further investigation into the therapeutic applications of selective H3-receptor agonists is warranted.